Literature DB >> 25192261

A peek into the atomic details of thalidomide's clinical effects.

Sagar Bhogaraju1, Ivan Dikic2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25192261     DOI： 10.1038/nsmb.2882

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN： 1545-9985            Impact factor:   15.369


× No keyword cloud information.
  13 in total

1.  Control of vertebrate limb outgrowth by the proximal factor Meis2 and distal antagonism of BMPs by Gremlin.

Authors:  J Capdevila; T Tsukui; C Rodríquez Esteban; V Zappavigna; J C Izpisúa Belmonte
Journal:  Mol Cell       Date:  1999-11       Impact factor: 17.970

Review 2.  Ikaros in immune receptor signaling, lymphocyte differentiation, and function.

Authors:  Matthias Merkenschlager
Journal:  FEBS Lett       Date:  2010-10-02       Impact factor: 4.124

3.  Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery.

Authors:  Stephane Angers; Ti Li; Xianhua Yi; Michael J MacCoss; Randall T Moon; Ning Zheng
Journal:  Nature       Date:  2006-10-05       Impact factor: 49.962

Review 4.  DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase.

Authors:  Jennifer Lee; Pengbo Zhou
Journal:  Mol Cell       Date:  2007-06-22       Impact factor: 17.970

5.  Biochemistry. The resolution revolution.

Authors:  Werner Kühlbrandt
Journal:  Science       Date:  2014-03-28       Impact factor: 47.728

6.  Identification of a primary target of thalidomide teratogenicity.

Authors:  Takumi Ito; Hideki Ando; Takayuki Suzuki; Toshihiko Ogura; Kentaro Hotta; Yoshimasa Imamura; Yuki Yamaguchi; Hiroshi Handa
Journal:  Science       Date:  2010-03-12       Impact factor: 47.728

7.  Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells.

Authors:  Jan Krönke; Namrata D Udeshi; Anupama Narla; Peter Grauman; Slater N Hurst; Marie McConkey; Tanya Svinkina; Dirk Heckl; Eamon Comer; Xiaoyu Li; Christie Ciarlo; Emily Hartman; Nikhil Munshi; Monica Schenone; Stuart L Schreiber; Steven A Carr; Benjamin L Ebert
Journal:  Science       Date:  2013-11-29       Impact factor: 47.728

8.  Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs.

Authors:  Philip P Chamberlain; Antonia Lopez-Girona; Karen Miller; Gilles Carmel; Barbra Pagarigan; Barbara Chie-Leon; Emily Rychak; Laura G Corral; Yan J Ren; Maria Wang; Mariko Riley; Silvia L Delker; Takumi Ito; Hideki Ando; Tomoyuki Mori; Yoshinori Hirano; Hiroshi Handa; Toshio Hakoshima; Thomas O Daniel; Brian E Cathers
Journal:  Nat Struct Mol Biol       Date:  2014-08-10       Impact factor: 15.369

Review 9.  The thalidomide saga.

Authors:  Magda Melchert; Alan List
Journal:  Int J Biochem Cell Biol       Date:  2007-01-30       Impact factor: 5.085

10.  Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide.

Authors:  Eric S Fischer; Kerstin Böhm; John R Lydeard; Haidi Yang; Michael B Stadler; Simone Cavadini; Jane Nagel; Fabrizio Serluca; Vincent Acker; Gondichatnahalli M Lingaraju; Ritesh B Tichkule; Michael Schebesta; William C Forrester; Markus Schirle; Ulrich Hassiepen; Johannes Ottl; Marc Hild; Rohan E J Beckwith; J Wade Harper; Jeremy L Jenkins; Nicolas H Thomä
Journal:  Nature       Date:  2014-07-16       Impact factor: 49.962
View more
  1 in total

Review 1.  Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway.

Authors:  Ian Collins; Hannah Wang; John J Caldwell; Raj Chopra
Journal:  Biochem J       Date:  2017-03-15       Impact factor: 3.857
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.